- Home
- BIO vs VNO Comparison
BIO vs VNO Comparison
Compare BIO & VNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIO
- VNO
- Stock Information
- Founded
- BIO 1952
- VNO 1946
- Country
- BIO United States
- VNO United States
- Employees
- BIO N/A
- VNO N/A
- Industry
- BIO Biotechnology: Laboratory Analytical Instruments
- VNO Real Estate Investment Trusts
- Sector
- BIO Industrials
- VNO Real Estate
- Exchange
- BIO Nasdaq
- VNO Nasdaq
- Market Cap
- BIO 6.6B
- VNO 7.3B
- IPO Year
- BIO N/A
- VNO N/A
- Fundamental
- Price
- BIO $264.53
- VNO $36.21
- Analyst Decision
- BIO Strong Buy
- VNO Hold
- Analyst Count
- BIO 4
- VNO 11
- Target Price
- BIO $333.50
- VNO $38.00
- AVG Volume (30 Days)
- BIO 342.3K
- VNO 1.6M
- Earning Date
- BIO 07-31-2025
- VNO 08-04-2025
- Dividend Yield
- BIO N/A
- VNO 2.00%
- EPS Growth
- BIO N/A
- VNO 4453.28
- EPS
- BIO 11.49
- VNO 4.07
- Revenue
- BIO $2,554,200,000.00
- VNO $1,889,783,000.00
- Revenue This Year
- BIO N/A
- VNO N/A
- Revenue Next Year
- BIO $3.42
- VNO $4.81
- P/E Ratio
- BIO $22.99
- VNO $9.06
- Revenue Growth
- BIO N/A
- VNO 0.58
- 52 Week Low
- BIO $211.43
- VNO $29.68
- 52 Week High
- BIO $387.99
- VNO $46.63
- Technical
- Relative Strength Index (RSI)
- BIO 55.27
- VNO 38.80
- Support Level
- BIO $261.65
- VNO $35.89
- Resistance Level
- BIO $270.71
- VNO $38.35
- Average True Range (ATR)
- BIO 8.66
- VNO 1.18
- MACD
- BIO -0.13
- VNO -0.31
- Stochastic Oscillator
- BIO 46.22
- VNO 20.12
About BIO Bio-Rad Laboratories Inc.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
About VNO Vornado Realty Trust
Vornado owns and has an ownership interest in Class A office and retail properties highly concentrated in Manhattan, with additional properties in San Francisco and Chicago. It operates as a real estate investment trust.